Insider · CIK 0001377582

Celano Michael

Reports to the SEC for 4 companies · BALA CYNWYD, PA

sec.gov

Transactions

Companies

Filings

CIK

0001377582

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-01-26	LRMRLarimar Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+226K sh	—	—	225,622
2026-01-26	LRMRLarimar Therapeutics, Inc.A Award	Chief Financial Officer	AAward	+37.6K sh	—	—	215,785
2025-01-22	LRMRLarimar Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+205K sh	—	—	205,111
2025-01-22	LRMRLarimar Therapeutics, Inc.A Award	Chief Financial Officer	AAward	+34.2K sh	—	—	178,181
2024-01-17	LRMRLarimar Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+188K sh	—	—	187,500
2024-01-17	LRMRLarimar Therapeutics, Inc.A Award	Chief Financial Officer	AAward	+31.3K sh	—	—	143,996
2023-05-17	LRMRLarimar Therapeutics, Inc.P Purchase	Chief Financial Officer	PPurchase	+5,000 sh	$3.73	+$18.6K	112,746
2023-01-31	LRMRLarimar Therapeutics, Inc.A Award	Chief Financial Officer	AAward	+76K sh	—	—	107,746
2023-01-31	LRMRLarimar Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+120K sh	—	—	120,000
2022-09-16	LRMRLarimar Therapeutics, Inc.P Purchase	Chief Financial Officer	PPurchase	+31.7K sh	$3.15	+$100K	31,746
2022-08-12	OSURORASURE TECHNOLOGIES INCP Purchase	Director	PPurchase	+12K sh	$4.49	+$53.9K	111,823
2022-05-16	OSURORASURE TECHNOLOGIES INCF Tax Payment	Director	FTax Payment	−3,399 sh	$5.25	−$17.8K	75,061
2022-05-16	OSURORASURE TECHNOLOGIES INCA Award	Director	AAward	+24.8K sh	$5.25	+$130K	99,823
2022-05-10	LRMRLarimar Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+20K sh	—	—	20,000
2022-01-18	LRMRLarimar Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+80K sh	—	—	80,000
2021-05-18	OSURORASURE TECHNOLOGIES INCA Award	Director	AAward	+13.6K sh	$9.59	+$130K	78,460
2021-05-17	OSURORASURE TECHNOLOGIES INCF Tax Payment	Director	FTax Payment	−2,041 sh	$9.50	−$19.4K	64,901
2021-01-19	LRMRLarimar Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+42K sh	—	—	42,000
2020-09-29	LRMRLarimar Therapeutics, Inc. · Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+84.1K sh	—	—	84,100
2020-05-28	LRMRLarimar Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+60.5K sh	—	—	60,479
2020-05-18	OSURORASURE TECHNOLOGIES INCA Award	Director	AAward	+8,143 sh	$15.96	+$130K	66,942
2020-05-15	OSURORASURE TECHNOLOGIES INCF Tax Payment	Director	FTax Payment	−3,843 sh	$16.04	−$61.6K	58,799
2019-05-21	OSURORASURE TECHNOLOGIES INCA Award	Director	AAward	+15.3K sh	$8.48	+$130K	62,642
2019-01-18	Societal CDMO, Inc.F Tax Payment	Chief Operating Officer	FTax Payment	−1,782 sh	$7.99	−$14.2K	44,063
2019-01-18	Societal CDMO, Inc.A Award	Chief Operating Officer	AAward	+12.7K sh	—	—	39,445
2019-01-18	Societal CDMO, Inc.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+6,400 sh	—	—	45,845
2019-01-18	Societal CDMO, Inc.Employee Stock Option (right to buy)A Award	Chief Operating Officer	AAward	+60.6K sh	—	—	60,592
2019-01-18	Societal CDMO, Inc.Restricted Stock UnitsM Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−6,400 sh	—	—	12,800
2019-01-18	Societal CDMO, Inc.A Award	Chief Operating Officer	AAward	+14.5K sh	—	—	41,237
2019-01-18	Societal CDMO, Inc.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+6,400 sh	—	—	47,637
2019-01-18	Societal CDMO, Inc.F Tax Payment	Chief Operating Officer	FTax Payment	−1,782 sh	$7.99	−$14.2K	45,855
2019-01-18	Societal CDMO, Inc.Employee Stock Option (right to buy)A Award	Chief Operating Officer	AAward	+67.5K sh	—	—	67,500
2019-01-18	Societal CDMO, Inc.Restricted Stock UnitsM Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−6,400 sh	—	—	12,800
2019-01-02	Societal CDMO, Inc.F Tax Payment	Chief Operating Officer	FTax Payment	−1,702 sh	$7.41	−$12.6K	26,773
2018-05-14	OSURORASURE TECHNOLOGIES INCF Tax Payment	Director	FTax Payment	−1,578 sh	$15.97	−$25.2K	47,312
2018-05-08	OSURORASURE TECHNOLOGIES INCA Award	Director	AAward	+7,762 sh	—	—	48,890
2018-04-01	OSURORASURE TECHNOLOGIES INC · Nonqualified stock optionsA Award	Director	AAward	+40K sh	—	—	40,000
2018-01-18	Societal CDMO, Inc.Restricted Stock UnitsM Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−6,400 sh	—	—	19,200
2018-01-18	Societal CDMO, Inc.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+6,400 sh	—	—	30,495
2018-01-18	Societal CDMO, Inc.F Tax Payment	Chief Operating Officer	FTax Payment	−2,020 sh	$8.89	−$18K	28,475
2018-01-02	Societal CDMO, Inc.Employee Stock Option (right to buy)A Award	Chief Operating Officer	AAward	+40K sh	—	—	40,000
2018-01-02	Societal CDMO, Inc.A Award	Chief Operating Officer	AAward	+20K sh	—	—	24,095
2017-09-28	Societal CDMO, Inc.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+6,000 sh	—	—	6,000
2017-09-28	Societal CDMO, Inc.F Tax Payment	Chief Operating Officer	FTax Payment	−1,905 sh	$9.04	−$17.2K	4,095
2017-05-16	OSURORASURE TECHNOLOGIES INCA Award	Director	AAward	+6,295 sh	—	—	41,128
2017-05-15	OSURORASURE TECHNOLOGIES INCF Tax Payment	Director	FTax Payment	−3,284 sh	$15.13	−$49.7K	34,833
2017-05-05	OSURORASURE TECHNOLOGIES INCS Sale	Director	SSale	−45K sh	$14.95	−$672K	38,117
2017-03-02	OSURORASURE TECHNOLOGIES INCS Sale	Director	SSale	−15K sh	$12.00	−$180K	83,079
2017-03-02	OSURORASURE TECHNOLOGIES INCM Exercise/Conversion	Director	MExercise/Conversion	+15K sh	$8.05	+$121K	98,079
2017-03-02	OSURORASURE TECHNOLOGIES INC · Nonqualified stock optionM Exercise/Conversion	Director	MExercise/Conversion	−15K sh	—	—	0

Recent filings

Accepted (ET)
Jan 274
Celano Michael0001193125-26-024824
SEC(opens sec.gov)
Jan 244
Celano Michael0001062993-25-001077
SEC(opens sec.gov)
Jan 194
Celano Michael0001062993-24-001085
SEC(opens sec.gov)
May 184
Celano Michael0001062993-23-011547
SEC(opens sec.gov)
Feb 24
Celano Michael0000899243-23-003735
SEC(opens sec.gov)
Sep 194
Celano Michael0001062993-22-019646
SEC(opens sec.gov)
Aug 164
Celano Michael0001062993-22-018107
SEC(opens sec.gov)
May 184
Celano Michael0001062993-22-012896
SEC(opens sec.gov)
May 124
Celano Michael0001062993-22-012308
SEC(opens sec.gov)
Jan 204
Celano Michael0001062993-22-001320
SEC(opens sec.gov)
May 194
Celano Michael0001593968-21-001355
SEC(opens sec.gov)
Jan 214
Celano Michael0001192482-21-000074
SEC(opens sec.gov)
Sep 304
Celano Michael0001192482-20-000745
SEC(opens sec.gov)
Jun 54
Celano Michael0001192482-20-000435
SEC(opens sec.gov)

Companies

Address

C/O LARIMAR THERAPEUTICS, INC. THREE BALA PLAZA EAST, SUITE 506

BALA CYNWYD, PA, 19004